Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...

Patients with chronic spontaneous urticaria (CSU) treated with remibrutinib (Rhapsido; Novartis) in the REMIX-1 ( NCT05030311 ...

Patients who take omalizumab prior to starting oral immunotherapy (OIT) may skip much of the latter treatment’s onerous dose ...

If Eli Lilly's obesity pill orforglipron is approved and priced around $200 per month, analysts at Truist predict patients ...

New study shows a longer course of dual antithrombotic therapy may not be necessary for some patients with atrial ...

Study shows potential of Canopy 's Remote Therapeutic Monitoring Platform to reduce infection-related hospitalizations and ER visits in patients treated ...

The Accreditation Association for Ambulatory Health Care (AAAHC) has accredited two additional U.S. Oral Surgery Management (USOSM) partner practices. They are North Sound Oral & Facial Surgery and ...

Agios Pharmaceuticals plans to share data from RISE UP with the Food and Drug Administration to support the approval of the sickle cell disease indication.

Enanta Pharmaceuticals, Inc.'s strong pipeline, positive RSV drug data, and solid cash position drive growth. Click for my ...

Here’s what the science says about what helps with a stuffy nose, what doesn’t and how else to breathe easier.

Researchers at University Medical Center Maastricht and international partners report that a single shot of the drug ...

Giredestrant significantly improves IDFS in ER-positive, HER2-negative early-stage breast cancer, surpassing standard ...